Allowing pharmacy benefit managers to continue with business-as-usual makes it impossible to build a health care ecosyste... Read more
The runaway bureaucratic expansion of 340B must stop, and this court ruling is an important step. ... Read more
The battle over the drug mifepristone comes after a tough stretch for the FDA: Controversy around the infant formula shor... Read more